2BB score and signals
Lexeo Therapeutics, Inc.’s current 2BB score is 53 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 77 | High |
| Momentum | 92 | Strongly Improving |
| Financial strength | 12 | Very Weak |
| Quality | 75 | Strong |
Lexeo Therapeutics, Inc. (LXEO) Stock Score & Signals
Lexeo Therapeutics, Inc. (LXEO) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 53 out of 100.
Company facts
| Founded | 2017 |
| Employees | 63 |
| 52-week range | $2.56 – $10.99 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-09 | — | -0.3355 | — | $0.00 |
| 2026-08-19 | — | -0.2907 | — | $0.00 |
| 2026-05-11 | -0.25 | -0.3196 | $0.00 | $0.00 |
| 2026-03-30 | -0.27 | -0.3208 | $0.00 | $0.00 |